Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Based on the article from Forbes.com, FDNA is leveraging facial detection to spot rare diseases in children through Face2Gene. This advanced AI technology analyzes facial features to identify genetic anomalies, providing rapid and accurate diagnostic suggestions. By comparing patient photos to a comprehensive database of known genetic conditions, Face2Gene enhances early disease detection. This facial detection approach significantly improves the accuracy and efficiency of expedited diagnosis of rare diseases. FDNA’s pioneering work demonstrates the transformative potential of AI in healthcare, aiming to deliver personalized treatment plans and improve outcomes for children with rare genetic disorders.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…